AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 29, 2024
The Union health ministry has issued final notification defining the clinical research organisations (CROs) and mandating registration for the organisations to operate under the New Drugs and Clinical Trials Rules (NDCTR), 2019. The amended rules will come into force from April 1, 2025.
Pharma Mirror
SEPTEMBER 29, 2024
In healthcare, safety is always the top priority—whether it's protecting patients or the staff who care for them. Personal protective equipment (PPE) plays a vital role in ensuring this safety, and one item that stands out is nitrile exam gloves. The post Why Nitrile Exam Gloves Are the Preferred Choice for Medical Professionals appeared first on Pharma Mirror Magazine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 29, 2024
(Engin Akyurt/Pixabay) If you’re in a lot of pain, being told to take deep breaths and accept the sensations in your body might not feel particularly comforting.
Drug Channels
SEPTEMBER 29, 2024
Informa Connect's Copay, Reimbursement and Access Congress November 18-20, 2024 | Hilton Penn’s Landing in Philadelphia, PA Drug Channels readers save 10% with code USAVE24 * The access and affordability landscape is undergoing a seismic shift. Evolving legislation, disruptive market forces and the ever-growing complexities of cost sharing programs threaten patient adherence and commercialization strategies.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Expert insights. Personalized for you.
246 
Let's personalize your content